ArticlePractical laboratory medicine2025
Exploring the impact of pre-analytical processes on the determination of neuron-specific enolase in serum samples.
Article in Practical laboratory medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore pre-analysis factors affecting the results of neuron-specific enolase (NSE) testing of serum samples, select optimal testing conditions, and reduce the false-positive rate of NSE. Methods: Serum NSE levels were measured using the Roche e801 electrochemiluminescence immunoassay in healthy participants who underwent physical examinations at the Fourth Affiliated Hospital of Soochow University from September 2022 to December 2024, including both outpatients and hospitalized patients. Further, we analyzed the effects of various pre-analytical factors on the NSE positivity rate (NSE>16.3 ng/mL was judged to be NSE-positive) and the proportion of hemolysis index (H) ≥13 (H = 13 was equivalent to hemoglobin concentration of 13 mg/dl). Results: This study found that the positive rate of NSE and the H ≥ 13 proportion were influenced by factors such as hemolysis, the method of sample transportation, pre-centrifugation storage time, the brand of blood collection tube, and centrifugation conditions. However, post-centrifugation storage time had little effect on these results. Conclusion: After blood collection, the NSE positive rate and the H ≥ 13 proportion significantly decreased using a gentler transportation method, such as a box logistics or manual transport, centrifuging within 30-40 min or no longer than 1 h at the latest post-collection, and centrifuging at 2100
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.